and hypertriglyceridemia in PCOS D (30% and 23.9%) was found to P096
be intermediate between that of PCOS C (24.5% and 18.4%) and PCOS A (47.3% and 27%). The high prevalence of hypercholesterolemia Abeta apolipoprotenaemia as a very rare cause (around 50%) was common feature of all groups. In conclusion, in of secondary amenorrhea women with PCOS, the presence of oligomenorrhea was associ- Christina Tzouma 1, , H. Milionis 2 , V.E. ated with higher prevalence of metabolic disturbances compared Hatzidakis 1 , M. Syrrou 3 , P. Messaropoulos 4 , M. with the presence of hyperandrogenism in both lean and obese Oikonomou 5 , I. Koutoulakis 6 , P. Drakakis 6 , S. women with PCOS. Obesity is more prevalent in hyperandrogenic Kalantaridou 1 PCOS phenotypes than in non-hyperandrogenic PCOS phenotype 1 University of Athens, Aretaieio Hospital, Unit of and controls. In obese controls, asymptomatic PCOM and PCOS women, the prevalence of cardiometabolic risk factors was much Primary Ovarian Insufciency, 2nd Department of higher than in their lean counterparts. Obstetrics and Gynaecology, Athens, Greece 2 University of Ioannina, Department of Internal
http://dx.doi.org/10.1016/j.maturitas.2017.03.194 Medicine, School of Medicine, Ioannina, Greece
3 Medical School, Laboratory of General Biology, P095 Ioannina, Greece 4 Tzaneio Hospital, General Hospital of Piraeus, Clinical condition of hypoleptinemia in patients Athens, Greece with weight loss-related amenorrhea 5 Thriassio Hospital, General Hospital of Elefsina,
6 University of Athens, Alexandra Maternity Kametani, Takahiro Suzuki, Hitoshi Ishimoto, Mikio Mikami Hospital, 1st Department of Obstetrics and Gynecology, Athens, Greece Tokai University, School of Medicine Department of Obstetrics and Gynecology, Isehara, Japan Aim: We report a rare case of secondary amenorrhea due to abeta apolipoprotenaemia. Objectives: Patients with weight loss-related amenorrhea Case report: A 28 year-old woman presented with secondary have been increasing in our modern society. As leptin is amenorrhea in the last 11-month period. She had menarche on secreted from adipose cell, low body weight induces decrease the age of 13 with normal development of secondary female char- of the secretion. Hypoleptinemia may impair the function of acteristics. Her BMI was low. A progesterone challenge test was hypothalamus-pituitary-ovary axis and result in amenorrhea as performed and was positive. Her gonadotropin levels at baseline well as immunological abnormality. To identify the pathological were FSH = 26 mIU/mL and LH = 22 mIU/mL. Her lipidaemic prole mechanism, we tried to analyze immunological and endocrine con- showed very low cholesterol values and non-detective levels of dition of in the patients of weight loss-related hypoleptinemia. apo-B. Her spinal Dexa scan showed a Z-score = 3.47. Furthermore, Methodology: According to the research protocol approved by she had vision disorders, especially on night vision and on colours IRB, 5 patients with weight loss-related amenorrhea and some nor- differentiation. These ndings suggested secondary amenorrhea mal menstrual women were recruited. Preliminarily, the endocrine due to abeta apolipoprotenaemia. prole and lymphocyte subsets by ow cytometry were analyzed. Conclusion: Abeta apolipoprotenaemia is a very rare cause of Results: All patients showed the low serum concentration of amenorrhea. Total cholesterol is used for steroid hormone synthe- leptin, gonadotropin and ovarian hormones, while normal ranges sis. Especially LDL is used for corpus luteum progesterone synthesis. in control women. The results of LH-RH load test in the patient Lipoprotein disorders with low lipid production may impair ovar- showed low reactivity in the patient group, indicating severe grade ian steroidogenesis. of hypothalamic amenorrhea. Whereas, the prole of lymphocyte subsets (CD4, CD8, and B cells) was within the normal range. http://dx.doi.org/10.1016/j.maturitas.2017.03.196 Conclusions: In this study, there was no signicant difference in constitution of lymphocyte between the two groups. Since a few P097 previously reported on this disease/condition, we should inten- sively try to investigate the changes before/after weight recovery Androgen excess in women A life long and at the immunological abnormal conditions such as pregnancy, problem infection and autoimmune disease. Johannes Bitzer , Aware
http://dx.doi.org/10.1016/j.maturitas.2017.03.195 University Hospital of Basel, Obstetrics Gynecology,
Basel, Switzerland
Introduction: Hyperandrogenism in women leads to skin and
hair disorders, metabolic disturbances and can increase cardiovas- cular and neoplastic risk. There are different treatment options including local and endocrine treatment. Objective: Dening the importance of the AEiW by summarizing the prevalence of Hyperandrogenic Skin Disorders and PCO. Perform a narrative review of studies about the efcacy, health risks, tolerability, and possible health benets of different treat- ment options. Results: Prevalence Acne: 8095% in adolescents and 5% in women beyond 40 Hirsutism: 515% with regional differences